Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,266
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,852
Class I recallsReasonable probability of serious health consequences
24,397
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of assurance of sterility 2,085 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2

Showing 61–80 of 21,683 recalls

FDA Recall Ongoing2026 recordClass II

THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 3ml - 0.1 fl. oz, Sachet: Single use only, Made in the U.S.A, Distributed by Allies Group Pte Ltd, Singapore 068914.UPC 8 885014 073293

by Allies Group Inc.

Reason
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 50ML - 1.7 fl. oz Tube, Made in U.S.A, Distributed by Allies Group Pte Ltd, Singapore 068914. UPC 8 885014 073224

by Allies Group Inc.

Reason
Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeton, NJ 08540 NDC 69452-206-20.

by Bionpharma Inc.

Reason
Presence of Foreign Tablets/Capsules
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3583-01.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-4114-50.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonpyrogenic, iso-osmotic solution in Dextrose, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in the USA, NDC 43066-360-20.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, NDC 0338-9648-12.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single Dose Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-9557-12.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyrogenic, Baxter International Inc., Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-5197-41.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3612-50.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3552-48.

by Baxter Healthcare Corporation

Reason
CGMP Deviations
Published
September 9, 2026
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.